Qiang Shen

机构：Peking University, Suzhou Research Institute, Louisiana State University Health Sciences Center New Orleans · ORCID：0000-0002-1491-5434

发表论文 364 篇 · 总被引 11916 次 · h-index 60

代表论文

• Deubiquitinase-Targeting Chimeras (DUBTACs) as a Potential Paradigm-Shifting Drug Discovery Approach (2025 · Journal of Medicinal Chemistry · 被引 25)
• RAS(ON) Therapies on the Horizon to Address KRAS Resistance: Highlight on a Phase III Clinical Candidate Daraxonrasib (RMC-6236) (2025 · Journal of Medicinal Chemistry · 被引 17)
• Rezatapopt (PC14586): A First-in-Class Small Molecule p53 Y220C Mutant Protein Stabilizer in Clinical Trials (2025 · Journal of Medicinal Chemistry · 被引 15)
• Real-time monitoring and optimization methods for user-side energy management based on edge computing (2025 · Scientific Reports · 被引 14)
• RIPTACs for Precision Cancer Therapy: A Novel Modality with the Inspiration of HLD-0915 as the First Candidate in Clinical Trials (2025 · Journal of Medicinal Chemistry · 被引 13)
• Dynamic evolution and formation mechanisms of aroma compounds in Qianmei 502 black tea during processing: insights from transcriptomic and metabolomic analyses (2025 · LWT · 被引 12)